COMPANY OVERVIEW

Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening invasive fungal infections due to candida, aspergillus and rare molds.

---

LOCATION

---

THERAPEUTIC AREAS

Infectious Disease

---

WEBSITE

https://amplyx.com/

---

CAREER WEBSITE

https://amplyx.com/#services

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Apr 28, 2021

Pfizer Acquires Amplyx Pharmaceuticals

Dec 3, 2020

Amplyx Announces Upcoming Virtual Data Presentations at 62nd American Society of Hematology (ASH) Annual Meeting

Oct 16, 2020

Amplyx to Present New Clinical and Preclinical Data for its Two Lead Programs at Upcoming Scientific Conferences

Aug 17, 2020

Amplyx Doses First Patient in Phase 2 Clinical Trial of Anti-BKV Monoclonal Antibody in Renal Transplant Recipients

Aug 5, 2020

Amplyx Pharmaceuticals Announces Participation in Multiple Upcoming Investor Conferences

For More Press Releases

---